enrofloxacin has been researched along with Canine Diseases in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (16.92) | 18.2507 |
2000's | 31 (47.69) | 29.6817 |
2010's | 18 (27.69) | 24.3611 |
2020's | 5 (7.69) | 2.80 |
Authors | Studies |
---|---|
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Albarracin, B; Altier, C; Cazer, C; Gröhn, YT; Osman, M | 1 |
Bae, S; Oh, T; Park, S | 1 |
Brame, B; Clegg, J; Souza, C | 1 |
Chan, WY; Hickey, EE; Hill, PB; Page, SW; Trott, DJ | 1 |
Croton, C; Gibson, JS; Haworth, M; Kalnins, NJ; Purcell, SL; Stewart, AJ | 1 |
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
Moyers, TD; Price, JM; Whittemore, JC | 1 |
Daniels, JB; Irom, SJ; Lakritz, J; Tracy, G | 1 |
Hafler, K; Mirabile, J; Sheridan, R | 1 |
Aeffner, F; Hall, MJ; Papenfuss, TL; Pressler, BM; Townsend, KL | 1 |
Altier, C; Aprea, VA; Cummings, KJ | 1 |
Friedrichs, KR; Monaghan, KN; Pinkos, AC; Sample, SH; Trepanier, LA | 1 |
Rebhun, RB; Seo, KW; Watson, KD; Withers, SS; York, D | 1 |
Gibson, TW; Nazarali, A; Rousseau, J; Singh, A; Walker, M; Weese, JS | 1 |
Baxter, CG; Vogelnest, LJ | 1 |
Cole, LK; Hillier, A; Kwochka, KW; Lehman, AM; Papich, MG; Smeak, DD | 1 |
Boothe, DM; Johnson, CM; Kaltenboeck, B; Shaheen, BW; Wang, C | 1 |
Barrera, R; Duque, J; Ferrusola, CO; Macías-García, B; Peña, F; Tapia, PR; Zaragoza, C | 1 |
Huang, HP; Lin, MY | 1 |
Astorga, RJ; Ginel, PJ; Gómez-Gascón, L; Huerta, B; Luque, I; Maldonado, A; Tarradas, C | 1 |
Choi, MJ; Damte, D; Gebru, E; Lee, SJ; Park, SC | 1 |
Govendir, M; Hansen, T; Malik, R; Muscatello, G; Norris, JM; Trott, DJ; Wigney, DI | 1 |
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
Bell, D; Cornell, KK; Epstein, J; Schmiedt, CW; Stratton-Phelps, M; Torres, BT; Uhl, EW; Zimmerman, S | 1 |
Fujii, N; Ishihara, K; Muramatsu, Y; Okubo, T; Sato, T; Tamura, Y; Ueno, H; Yokota, S | 1 |
Cooke, CL; Hirsh, DC; Jang, SS; Singer, RS | 1 |
Brockus, CW; Currin, MP; Greene, CE; Jones, CJ | 1 |
Brothers, AM; Gibbs, PS; Wooley, RE | 1 |
Ingrey, KT; Prescott, JF; Ren, J | 1 |
Messick, JB | 1 |
Boothe, DM; Rees, CA | 1 |
Bianciardi, P; Fasanella, A; Foglia Manzillo, V; Gradoni, L; Oliva, G; Pagano, A; Sorino, S; Trotta, T | 1 |
Batten, PO; Brown, MA; Burgess, TM; Doddy, FM; Hampshire, VA; Hudson, R; Koogler, TL; McAdams, DR; Post, LO | 1 |
Baş, AL; Corlu, M; Erganiş, O; Simşek, A | 1 |
Gonsalves-Hubers, T | 1 |
Baldi, PC; Delpino, MV; Wanke, MM | 1 |
Cole, LK; Hillier, A; Kelbick, NT; Kowalski, JJ; Kwochka, KW; Smeak, DD | 1 |
Olver, C; Thrall, MA; Williams, M | 1 |
Bernstein, JA; Cook, HE; Gill, AF; Ryan, KA; Sirninger, J | 1 |
Cavana, P; Farca, AM; Nebbia, P; Robino, P | 1 |
Moss, SM; Rees, R; See, AM; Trott, DJ | 1 |
Choi, SH; Hossain, MA; Kim, G; Lim, S; Park, J | 1 |
Bello, H; Domínguez, M; González, G; Guggiana, D; Moreno, A | 1 |
Manca, R; Minoia, G; Mutinati, M; Rizzo, A; Sciorsci, RL; Spedicato, M; Trisolini, C | 1 |
Budsberg, SC; Duval, JM | 1 |
Batt, RM; Elwood, CM; Rutgers, HC; Simpson, KW; Stepien, RL | 1 |
Dick, GC | 1 |
Ferguson, JF | 1 |
Boswood, A | 1 |
Farca, AM; Maffei, F; Piromalli, G; Re, G | 1 |
Harvey, CE; Miller, BR; Shofer, FS; Thornsberry, C | 1 |
Nuttall, T | 1 |
Brandt, CM; DeManuelle, TC; Ihrke, PJ; Kass, PH; Vulliet, PR | 1 |
Berridge, B; Bouley, D; Braniecki, A; Willard, MD | 1 |
Beck, JA; Simpson, DS | 1 |
Binns, SH; Corkill, JE; Dawson, S; Gaskell, RM; Hart, CA; Speakman, AJ | 1 |
Dobos-Kovács, M; Fodor, L; Makrai, L; Pelle, G | 1 |
Kelly, PJ | 1 |
Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
André-Fontaine, G; Ganière, JP; Limet, A; Médaille, C; Ruvoen, N | 1 |
Baş, AL; Civelek, T; Elmas, M; Maden, M; Traş, B; Yazar, E | 1 |
Bjorling, D; Fialkowski, JP; Lautzenhiser, SJ; Rosin, E | 1 |
Goering, RV | 1 |
Bas, L; Deĝim, T; Deĝim, Z; Elmas, M | 1 |
2 review(s) available for enrofloxacin and Canine Diseases
Article | Year |
---|---|
New perspectives about Hemotrophic mycoplasma (formerly, Haemobartonella and Eperythrozoon species) infections in dogs and cats.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Doxycycline; Enrofloxacin; Fluoroquinolones; Mycoplasma; Mycoplasma Infections; Quinolones | 2003 |
Canine ehrlichioses: an update.
Topics: Animals; Anti-Bacterial Agents; Bacterial Vaccines; Dog Diseases; Dogs; Ehrlichia; Ehrlichia ruminantium; Ehrlichiosis; Enrofloxacin; Fluoroquinolones; Humans; Imidocarb; Quinolones; Tetracyclines | 2000 |
6 trial(s) available for enrofloxacin and Canine Diseases
Article | Year |
---|---|
Treatment of moderate grade dog bite wounds using amoxicillin-clavulanic acid with and without enrofloxacin: a randomised non-inferiority trial.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bayes Theorem; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Microbial Sensitivity Tests; Staphylococcus | 2021 |
Randomized, controlled, crossover trial of prevention of antibiotic-induced gastrointestinal signs using a synbiotic mixture in healthy research dogs.
Topics: Animals; Anti-Bacterial Agents; Cross-Over Studies; Dog Diseases; Dogs; Eating; Enrofloxacin; Female; Gastrointestinal Diseases; Male; Metronidazole; Random Allocation; Synbiotics; Vomiting | 2019 |
Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Ear Canal; Enrofloxacin; Female; Fluoroquinolones; Injections, Intravenous; Male; Otitis Externa; Skin; Tissue Distribution | 2009 |
Use of enrofloxacin in the treatment of canine brucellosis in a dog kennel (clinical trial).
Topics: Agglutination Tests; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Brucella canis; Brucellosis; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Follow-Up Studies; Male; Pregnancy | 2006 |
Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Otitis Externa; Predictive Value of Tests; Severity of Illness Index | 2006 |
Influence of antibiotic therapy on serum levels of reactive oxygen species in ovariectomized bitches.
Topics: Amoxicillin; Anesthesia, General; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Lincomycin; Ovariectomy; Penicillin G; Postoperative Care; Preoperative Care; Reactive Oxygen Species; Sulfamethazine; Surgical Wound Infection | 2008 |
57 other study(ies) available for enrofloxacin and Canine Diseases
Article | Year |
---|---|
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Antimicrobial resistance trends among canine Escherichia coli isolated at a New York veterinary diagnostic laboratory between 2007 and 2020.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; New York; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
The stability and in vitro antibacterial efficacy of enrofloxacin and gentamicin solutions against Staphylococcus pseudintermedius over 28 days.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dexamethasone; Dog Diseases; Dogs; Enrofloxacin; Gentamicins; Microbial Sensitivity Tests; Otitis Externa; Saline Solution | 2023 |
Tolerability of Otic Solutions Containing Different Enrofloxacin Concentrations in Dogs with Healthy Ears.
Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin | 2023 |
Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Topics: Acetylcysteine; Animals; Anti-Infective Agents; Bacteria; Biofilms; Dog Diseases; Dogs; Edetic Acid; Enrofloxacin; Ionophores; Microbial Sensitivity Tests; Monensin; Otitis Externa; Pyrans | 2019 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
Fluoroquinolone levels in healthy dog urine following a 20-mg/kg oral dose of enrofloxacin exceed mutant prevention concentration targets against Escherichia coli isolated from canine urinary tract infections.
Topics: Animals; Antineoplastic Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Mutation; Urinary Tract Infections | 2014 |
Determination of six illegal antibiotics in chicken jerky dog treats.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Chickens; Dog Diseases; Dogs; Enrofloxacin; Fanconi Syndrome; Fluoroquinolones; Food Contamination; Meat Products; Sulfamethoxazole; Sulfaquinoxaline; Veterinary Drugs | 2014 |
Pathology in practice. Intestinal pythiosis in a dog.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Pythiosis; Pythium | 2015 |
Antimicrobial resistance trends among canine Escherichia coli isolates obtained from clinical samples in the northeastern USA, 2004-2011.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Logistic Models; Multivariate Analysis; New England; Tetracycline; Time Factors | 2015 |
Transient cold agglutinins associated with Mycoplasma cynos pneumonia in a dog.
Topics: Anemia, Hemolytic, Autoimmune; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Mycoplasma; Mycoplasma Infections; Pneumonia, Bacterial | 2015 |
Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Doxorubicin; Enrofloxacin; Fluoroquinolones; Osteosarcoma; Tumor Suppressor Protein p53 | 2017 |
Evaluation of the Impact of Methicillin-Resistant Staphylococcus pseudintermedius Biofilm Formation on Antimicrobial Susceptibility.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Canada; Cefazolin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Gentamicins; Methicillin Resistance; Plankton; Staphylococcal Infections; Staphylococcus; United States | 2016 |
Multifocal papular deep bacterial pyoderma in a Boxer dog caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Cyclosporine; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Immunohistochemistry; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma; Treatment Outcome | 2008 |
Detection of fluoroquinolone resistance level in clinical canine and feline Escherichia coli pathogens using rapid real-time PCR assay.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; DNA Gyrase; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluorescence Resonance Energy Transfer; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Urine | 2009 |
Two unusual cases of canine prostatitis: prostatitis in a castrated dog and preputial oedema in an intact male.
Topics: 5-alpha Reductase Inhibitors; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin; Estrogen Antagonists; Finasteride; Fluoroquinolones; Male; Orchiectomy; Prostatitis; Streptococcal Infections; Tamoxifen | 2010 |
Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni.
Topics: Animals; Antiprotozoal Agents; Babesia; Babesiosis; Diminazene; Dog Diseases; Dogs; Doxycycline; Drug Therapy, Combination; Enrofloxacin; Female; Fluoroquinolones; Male; Metronidazole; Retrospective Studies; Taiwan; Tick-Borne Diseases | 2010 |
Risk factors associated with the antimicrobial resistance of staphylococci in canine pyoderma.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Male; Methicillin; Pyoderma; Risk Factors; Staphylococcus | 2011 |
Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Selection, Genetic; Sequence Analysis, DNA; Time Factors | 2011 |
Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Ciprofloxacin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Nocardia; Nocardia Infections | 2011 |
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
Treatment of intestinal pythiosis in a dog with a combination of marginal excision, chemotherapy, and immunotherapy.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Intestinal Diseases; Itraconazole; Male; Naphthalenes; Pythiosis; Pythium; Terbinafine; Vaccines | 2012 |
Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
Topics: Animals; Anti-Infective Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections.
Topics: Animals; Anti-Infective Agents; Bacteriuria; Chromosome Banding; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Quinolones; Urinary Tract Infections | 2002 |
Infection with Basidiobolus ranarum in two dogs.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Dog Diseases; Dogs; Enrofloxacin; Entomophthorales; Fatal Outcome; Female; Fluoroquinolones; Itraconazole; Liver; Quinolones; Treatment Outcome; Water Microbiology; Zygomycosis | 2002 |
Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Klebsiella; Microbial Sensitivity Tests; Otitis Externa; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Staphylococcus; Urinary Tract Infections | 2002 |
A fluoroquinolone induces a novel mitogen-encoding bacteriophage in Streptococcus canis.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Blotting, Southern; DNA, Viral; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Mitogens; Mitomycin; Molecular Sequence Data; Pokeweed Mitogens; Polymerase Chain Reaction; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus Phages; Virulence | 2003 |
Evaluation of the effect of cephalexin and enrofloxacin on clinical laboratory measurements of urine glucose in dogs.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cephalexin; Cross-Over Studies; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enrofloxacin; False Negative Reactions; False Positive Reactions; Female; Fluoroquinolones; Glucose; Glycosuria; Quinolones; Random Allocation | 2004 |
The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Enrofloxacin; Female; Fluoroquinolones; In Vitro Techniques; Leishmania infantum; Leishmaniasis; Macrophage Activation; Male; Metronidazole; Quinolones; Trypanocidal Agents | 2004 |
Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Blindness; Cat Diseases; Cats; Databases, Factual; Dog Diseases; Dogs; Drug Overdose; Enrofloxacin; Equipment Failure; Etodolac; Fluoroquinolones; Horse Diseases; Horses; Keratoconjunctivitis Sicca; Legislation, Drug; Macrolides; Quinolones; Syringes; United States; United States Food and Drug Administration; Veterinary Drugs | 2004 |
Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Enrofloxacin; Fluoroquinolones; Liposomes; Male; Monocytes; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2005 |
Pemphigus erythematosus in a chow chow.
Topics: Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Enrofloxacin; Female; Fluoroquinolones; Immunosuppressive Agents; Pemphigus; Skin Diseases; Treatment Outcome | 2005 |
Transtracheal wash from a puppy with respiratory disease.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Male; Mycoplasma Infections; Respiratory Tract Infections; Trachea | 2006 |
Cytologic diagnosis of generalized cutaneous sporotrichosis in a hunting hound.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Clindamycin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Itraconazole; Male; Sporotrichosis | 2007 |
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome | 2007 |
Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Silver Sulfadiazine | 2007 |
The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro.
Topics: Achilles Tendon; Animals; Antineoplastic Agents; Apoptosis; Cartilage Diseases; Cell Proliferation; Chondrocytes; DNA Fragmentation; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enrofloxacin; Fluoroquinolones; Tendinopathy; Time Factors | 2008 |
Extended-spectrum beta-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Feces; Fluoroquinolones | 2008 |
Cortical bone concentrations of enrofloxacin in dogs.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Bone and Bones; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Osteomyelitis; Quinolones | 1995 |
Enrofloxacin treatment of gram-negative infections.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacterial Infections; Pseudomonas Infections; Quinolones; Salmonella Infections, Animal | 1994 |
Use of enrofloxacin.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Pyoderma; Quinolones; Skin Diseases, Bacterial | 1993 |
What is your diagnosis?. Infected fracture with secondary osteomyelitis.
Topics: Animals; Anti-Infective Agents; Bone Plates; Bone Transplantation; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Fracture Fixation, Intramedullary; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Radiography; Tibial Fractures; Wound Infection | 1995 |
Resolution of dysrhythmias and conduction abnormalities following treatment for bacterial endocarditis in a dog.
Topics: Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Dog Diseases; Dogs; Electrocardiography; Endocarditis, Bacterial; Enrofloxacin; Fluoroquinolones; Heart Conduction System; Quinolones | 1996 |
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine | 1997 |
Antimicrobial susceptibility of subgingival bacterial flora in dogs with gingivitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Anaerobic; Cefadroxil; Clindamycin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Gingivitis; Microbial Sensitivity Tests; Periodontal Pocket; Quinolones; Statistics, Nonparametric | 1995 |
What is your diagnosis? Mucocutaneous ulceration.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Cephalexin; Cephalosporins; Diagnosis, Differential; Dog Diseases; Dogs; Enrofloxacin; Erythema Multiforme; Fluoroquinolones; Male; Otitis Externa; Quinolones | 1998 |
Determination of skin concentrations of enrofloxacin in dogs with pyoderma.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biopsy; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Inflammation; Microbial Sensitivity Tests; Pyoderma; Quinolones; Skin; Staphylococcus | 1998 |
Possible antibiotic-associated colitis in a dog.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colitis; Colon; Colonoscopy; Diarrhea; Dog Diseases; Dogs; Enrofloxacin; Fatal Outcome; Fluoroquinolones; Gastrointestinal Hemorrhage; Male; Quinolones | 1998 |
Surgical treatment of gastric leiomyoma in a dog.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Gastric Outlet Obstruction; Gastroscopy; Leiomyoma; Male; Penicillin G; Penicillins; Pyloric Antrum; Quinolones; Radiography; Stomach; Stomach Neoplasms; Ultrasonography; Vomiting | 1999 |
Antibiotic susceptibility of canine Bordetella bronchiseptica isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bordetella bronchiseptica; Bordetella Infections; DNA, Bacterial; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Penicillins; Quinolones; R Factors; Sulfadiazine; Tetracycline; Trimethoprim | 2000 |
Actinomycosis of dogs caused by Actinomyces hordeovulneris.
Topics: Actinomyces; Actinomycosis; Amoxicillin; Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Empyema, Pleural; Enrofloxacin; Fatal Outcome; Fluoroquinolones; Lung Diseases; Male; Microbial Sensitivity Tests; Pericarditis; Pericardium; Pleura; Pleurisy; Quinolones; Sulfamethoxazole; Trimethoprim | 2000 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Pyoderma; Quinolones; Staphylococcal Infections; Staphylococcus | 2001 |
Investigation of biochemical and haematological side-effects of enrofloxacin in dogs.
Topics: Acidosis; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Bilirubin; Blood Gas Analysis; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Quinolones; Sodium | 2001 |
In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Combinations; Drug Synergism; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2001 |
Questions study on Escherichia coli susceptibility.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 2002 |
The use of liposomal enrofloxacin for intracellular infections in Kangal dogs and visualization of phagocytosis of liposomes.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Dog Diseases; Dogs; Drug Carriers; Enrofloxacin; Fluoroquinolones; Liposomes; Macrophages; Monocytes; Neutrophils; Phagocytosis; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2002 |